Computational studies on bacterial secondary metabolites against breast cancer

Microbes exist in the human body provide more benefits by modulating metabolic processes, immunity, and signal transduction. However, microbial dysbiosis with harmful bacterial species can cause chronic inflammation and cancers. Hence human probiotics were recently paid more attention to immune responses, therapy, and diagnosis. Breast cancer is the second leading cancer worldwide and causes more death in women. The role of breast microbiome secondary metabolites in breast cancer is poorly studied. Research shows that breast has a specific microbiome inhabited with particular bacterial species. More significantly probiotics produced from breast microbiomes may act as a potential biomarker for breast cancer diagnosis. Hence this computational research aimed at the effect of chosen metabolites on breast cancer cell receptor G-protein-coupled bile acid receptor, Gpbar1 (TGR5). The current research suggested that cadaverine, succinate,p-cresol, and its derivatives could be used as a molecular marker in the diagnosis of breast cancer.

Automated summary

Microbes in the human body have beneficial effects on metabolic processes, immunity, and signal transduction, with probiotics from the breast microbiome potentially serving as a biomarker for breast cancer diagnosis. Specific bacterial species inhabit the breast microbiome, and certain metabolites such as cadaverine, succinate, p-cresol, and its derivatives could be utilized as molecular markers in breast cancer diagnosis.